Anipamil is a calcium channel blocker, specifically of the phenylalkylamine type.
 This type is separate from its more common cousin Dihydropyridine.
 Anipamil is an analog of the more common drug verapamil, which is the most common type of phenylalkylamine style calcium channel blocker.
 Anipamil has been shown to be a more effective antiarrhythmic medication than verapamil because it does not cause hypertension as seen in verapamil.
 It is able to do this by bonding to the myocardium tighter then verapamil.
A media type (also MIME type and content type) is a two-part identifier for file formats and format contents transmitted on the Internet.
 The Internet Assigned Numbers Authority (IANA) is the official authority for the standardization and publication of these classifications.
 Media types were originally defined in Request for Comments 2045 in November 1996 as a part of "MIME (Multipurpose Internet Mail Extensions)" specification, for denoting type of email message content and attachments; hence the name "MIME type".
 Media types are also used by other internet protocols such as HTTP and document file formats such as HTML, for similar purpose.
"Maturity onset diabetes of the young" (MODY) refers to any of several hereditary forms of diabetes mellitus caused by mutations in an autosomal dominant gene disrupting insulin production.
 MODY is often referred to as "monogenic diabetes" to distinguish it from the more common types of diabetes (especially type 1 and type 2), which involve more complex combinations of causes involving multiple genes and environmental factors.
 MODY 2 and MODY 3 are the most common forms.
 MODY should not be confused with latent autoimmune diabetes of adults (LADA) — a form of type 1 DM, with slower progression to insulin dependence than child-onset type 1 DM, and which occurs later in life.
Claudia is a Polish language monthly women's magazine published in Warsaw, Poland.
Cis AB is a rare mutation in the ABO gene which complicates the basic inheritance pattern and blood-transfusion compatibility matching for ABO blood typing.
 There are different DNA mutations of either type A or Type B alleles that change several amino acids in enzyme transferase A or B, homologous enzymes differing in only four of 354 amino acids (R176G, G235S, L266M, and G268A).
 A single change in ABO gene DNA could reverse type B to type A and then, a new hybrid enzyme will produce both weak B and A2 (in serum test, A2B and A2B3)).
 The most common mutation is an A105 allele variation in exon 7 nucleotide position G803C changing Glycine (type A) to Alanine (type B).
 There are another 8 alleles reported in BGMUT, the most discovered reciently in China and Taiwan.
 In the cis-AB genotype, both antigens are expressed, like in a standard (trans) AB genotype.
 In a traditional AB phenotype, A and B antigenes are inherited separately from the father and mother while a cis-AB allele comes from one parent only.
 In a serum test, cis-AB tests almost the same as a traditional AB, but people with this rare type have problems with blood transfusions.
 Some of them need components like washed red blood cells or autotransfusion of serum and blood.
JAK1 is a human tyrosine kinase protein essential for signaling for certain type I and type II cytokines.
 It interacts with the common gamma chain (γc) of type I cytokine receptors, to elicit signals from the IL-2 receptor family (e.g. IL-2R, IL-7R, IL-9R and IL-15R), the IL-4 receptor family (e.g. IL-4R and IL-13R), the gp130 receptor family (e.g. IL-6R, IL-11R, LIF-R, OSM-R, cardiotrophin-1 receptor (CT-1R), ciliary neurotrophic factor receptor (CNTF-R), neurotrophin-1 receptor (NNT-1R) and Leptin-R).
 It is also important for transducing a signal by type I (IFN-α/β) and type II (IFN-γ) interferons, and members of the IL-10 family via type II cytokine receptors. Jak1 plays a critical role in initiating responses to multiple major cytokine receptor families.
 Loss of Jak1 is lethal in neonatal mice, possibly due to difficulties suckling.
 Expression of JAK1 in cancer cells enables individual cells to contract, potentially allowing them to escape their tumor and metastasize to other parts of the body.
Skin cancer, or neoplasia, is the most common type of cancer diagnosed in horses, accounting for 45 to 80% of all cancers diagnosed.
 Sarcoids are the most common type of skin neoplasm and are the most common type of cancer overall in horses.
 Squamous-cell carcinoma is the second-most prevalent skin cancer, followed by melanoma.
 Squamous-cell carcinoma and melanoma usually occur in horses greater than 9-years-old, while sarcoids commonly affect horses 3 to 6 years old.
 Surgical biopsy is the method of choice for diagnosis of most equine skin cancers, but is contraindicated for cases of sarcoids.
 Prognosis and treatment effectiveness varies based on type of cancer, degree of local tissue destruction, evidence of spread to other organs (metastasis) and location of the tumor.
 Not all cancers metastasize and some can be cured or mitigated by surgical removal of the cancerous tissue or through use of chemotherapeutic drugs.
Uterine cancer or womb cancer is any type of cancer that emerges from the tissue of the uterus.
 It can refer to several types of cancer, with cervical cancer (arising from the lower portion of the uterus) being the most common type worldwide and the second most common cancer in women in developing countries.
 Endometrial cancer (or cancer of the inner lining of the uterus) is the second most common type, and fourth most common cancer in women from developed countries.
 Risk factors depend on specific type, but obesity, older age, and human papillomavirus infection add the greatest risk of developing uterine cancer.
 Early on, there may be no symptoms, but irregular vaginal bleeding, pelvic pain or fullness may develop.
 If caught early, most types of uterine cancer can be cured using surgical or medical methods.
 When the cancer has extended beyond the uterine tissue, more advanced treatments including combinations of chemotherapy, radiation therapy, or surgery may be required.
Hennes was a women's magazine published in Sweden.
 The magazine was in circulation between 1961 and 2009.
Dibao (), literally "reports from the [official] residences", were a type of publications issued by central and local governments in imperial China.
 While closest in form and function to gazettes in the Western world, they have also been called "palace reports" or "imperial bulletins".
 Different sources place their first publication as early as the Han Dynasty (206 BC–220 AD) or as late as the Tang Dynasty (June 18, 618–June 4, 907).
 They contained official announcements and news, and were intended to be seen only by bureaucrats (and a given "dibao" might only be intended for a certain subset of bureaucrats).
 Selected items from a gazette might then be conveyed to local citizenry by word of mouth and/or posted announcements.
 Frequency of publication varied widely over time and place.
 Before the invention of moveable type printing they were hand-written or printed with engraved wooden blocks.
 The introduction of European-style Chinese language newspapers, along with the growing intersection of Chinese and global affairs generally, applied pressure for the Dibao to adapt, and circulation of the "Beijing Gazette" was in the tens of thousands by the time publication ceased altogether with the fall of the Qing Dynasty in 1911.
 The gazettes from Beijing at this time were known as "Jingbao" (京報), literally "reports from the capital".

Question: What type of publication does Hennes and Claudia have in common?
Answer: magazine